Opinion

Video

Payer and Reimbursement Considerations for Bispecific Therapies

Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.

Video content above is prompted by the following:

How do payer and reimbursement considerations affect access to bispecific therapies in different practice settings?

Related Videos
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
5 experts are featured in this series
4 experts are featured in this series.
3 experts are featured in this series.
4 experts are featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo